Zyus Life Sciences Corporation (ZYUS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 836 | 965 | 3,978 | 7,320 | 16,511 |
| Marketable Securities | 0 | 1,588 | 1,874 | 1,794 | 1,840 |
| Receivables | 1,096 | 789 | 627 | 522 | 391 |
| Inventories | 2,047 | 2,213 | 2,042 | 3,952 | 4,064 |
| Other current assets | 468 | 691 | 867 | 2,000 | 1,439 |
| TOTAL | $4,447 | $6,246 | $9,388 | $15,588 | $24,245 |
| Non-Current Assets | |||||
| PPE Net | 12,599 | 13,347 | 13,894 | 14,926 | 15,646 |
| Intangibles | 18,589 | 18,476 | 18,193 | 41,163 | 40,450 |
| Other Non-Current Assets | 152 | 152 | 152 | 156 | 156 |
| TOTAL | $31,340 | $31,975 | $32,239 | $56,245 | $56,252 |
| Total Assets | $35,787 | $38,221 | $41,627 | $71,833 | $80,497 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,575 | 6,106 | 6,149 | 7,155 | 7,401 |
| Accounts payable and accrued liabilities | N/A | N/A | 3,435 | N/A | N/A |
| Accrued Expenses | N/A | N/A | 3,256 | N/A | N/A |
| TOTAL | $15,063 | $12,805 | $13,244 | $13,753 | $17,869 |
| Non-Current Liabilities | |||||
| Long Term Debt | 686 | 745 | 637 | 707 | 1,079 |
| TOTAL | $5,194 | $5,345 | $5,269 | $11,346 | $11,661 |
| Total Liabilities | $20,257 | $18,150 | $18,513 | $25,099 | $29,530 |
| Shareholders' Equity | |||||
| Common Shares | 154,088 | 154,088 | 154,088 | 152,880 | 155,703 |
| Retained earnings | -148,337 | -143,525 | -140,187 | -115,702 | -114,251 |
| Other shareholders' equity | 4,161 | 4,071 | 3,820 | 4,398 | 3,856 |
| TOTAL | $15,530 | $20,071 | $23,114 | $46,734 | $50,967 |
| Total Liabilities And Equity | $35,787 | $38,221 | $41,627 | $71,833 | $80,497 |